These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17228079)

  • 1. Antiplatelet treatment for coronary heart disease.
    Clappers N; Brouwer MA; Verheugt FW
    Heart; 2007 Feb; 93(2):258-65. PubMed ID: 17228079
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiplatelet rather than anticoagulant therapy with coronary stenting.
    More RS; Chauhan A
    Lancet; 1997 Jan; 349(9046):146-7. PubMed ID: 9111532
    [No Abstract]   [Full Text] [Related]  

  • 3. Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts following percutaneous transluminal coronary angioplasty.
    Stein PD; Dalen JE; Goldman S; Schwartz L; Turpie AG; Théroux P
    Chest; 1992 Oct; 102(4 Suppl):508S-515S. PubMed ID: 1395831
    [No Abstract]   [Full Text] [Related]  

  • 4. Changing roles of anticoagulant and antiplatelet treatment during percutaneous coronary intervention.
    Kelly RV; Steinhubl S
    Heart; 2005 Jun; 91 Suppl 3(Suppl 3):iii16-9. PubMed ID: 15919646
    [No Abstract]   [Full Text] [Related]  

  • 5. Regarding antithrombotic treatment after coronary stenting in patients on chronic oral anticoagulation.
    Rubboli A; Colletta M; Di Pasquale G
    Am Heart J; 2005 Feb; 149(2):E1. PubMed ID: 15846242
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of enoxaparin in the invasive management of the ACS patient.
    Hermiller JB
    J Invasive Cardiol; 2004 Feb; 16(2):52-3. PubMed ID: 14760189
    [No Abstract]   [Full Text] [Related]  

  • 7. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents.
    Schömig A; Neumann FJ; Kastrati A; Schühlen H; Blasini R; Hadamitzky M; Walter H; Zitzmann-Roth EM; Richardt G; Alt E; Schmitt C; Ulm K
    N Engl J Med; 1996 Apr; 334(17):1084-9. PubMed ID: 8598866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anticoagulants and antiaggregants in ischemic heart disease].
    Motolese M
    G Ital Cardiol; 1990 Aug; 20(8):746-57. PubMed ID: 2272424
    [No Abstract]   [Full Text] [Related]  

  • 9. New players in the field of antiplatelet and anticoagulant therapy in coronary heart disease - current therapeutic issues and hot topics.
    Schindler C
    Ther Adv Cardiovasc Dis; 2009 Dec; 3(6):413-21. PubMed ID: 19917636
    [No Abstract]   [Full Text] [Related]  

  • 10. Angioplasty, restenosis, and antiplatelet therapy.
    Cooke RH; Kent KM
    Transplant Proc; 1989 Aug; 21(4):3685. PubMed ID: 2527427
    [No Abstract]   [Full Text] [Related]  

  • 11. Times they are a-changin.
    King SB
    JACC Cardiovasc Interv; 2012 Mar; 5(3):364-5. PubMed ID: 22440508
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapeutic options in coronary artery disease: focusing on the guidelines.
    Schwartz L
    Can J Cardiol; 2009 Jan; 25(1):19-24. PubMed ID: 19148338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Glycoprotein IIb/IIIa antagonists].
    Hennemann A
    Med Monatsschr Pharm; 2000 Dec; 23(12):385-90. PubMed ID: 11147193
    [No Abstract]   [Full Text] [Related]  

  • 14. Optimization of platelet therapy.
    Fry JA; Grines CL
    Semin Interv Cardiol; 2000 Sep; 5(3):117-28. PubMed ID: 11054909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelets and coronary artery disease.
    Handin RI
    N Engl J Med; 1996 Apr; 334(17):1126-7. PubMed ID: 8598874
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of hyperlipidaemia after coronary revascularisation: follow up study.
    Delacrétaz E; Michalopoulos PG; Ruiz J; Saner H; Meier B
    BMJ; 1998 May; 316(7143):1499. PubMed ID: 9582137
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical overview of promising nonthienopyridine antiplatelet agents.
    Angiolillo DJ; Guzman LA
    Am Heart J; 2008 Aug; 156(2 Suppl):S23-8. PubMed ID: 18657683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial progenitor cell capturing stent and short dual antiplatelet therapy in patients on chronic anti-vitamin k regimen undergoing percutaneous coronary interventions: long-term outcomes of a single centre registry.
    Martin-Yuste V; Brugaletta S; Ferreira-González I; Cola C; Alvarez-Contreras L; de Antonio M; Martí V; García-Picart J; Sabaté M
    EuroIntervention; 2011 Feb; 6(7):831-7. PubMed ID: 21252017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IIb/IIIa platelet inhibitors in the management of coronary artery disease.
    Talley JD
    J Ark Med Soc; 1996 Oct; 93(5):237-9. PubMed ID: 8908943
    [No Abstract]   [Full Text] [Related]  

  • 20. Surgery or percutaneous coronary intervention for three-vessel and left main coronary artery disease: a critical appraisal of the literature.
    Alison P; Sidebotham D
    N Z Med J; 2007 Jun; 120(1255):U2557. PubMed ID: 17546105
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.